The government this morning announced it has an in-principle agreement with Johnson & Johnson subsidiary Janssen Pharmaceutica for five million orders of their vaccine, pending success in clinical trials.
Research, Science and Innovation Minister Megan Woods said the agreement would allow the
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).